Spineart is pleased to announce the first worldwide surgery of TEKTONA®2, the new Vertebral Fragment Reduction System.
On January 4th 2021, Dr Slawomir Moszko, neurosurgeon and vice chief of the Department of Neurosurgery, Spine Surgery and Interventional Neuroradiology successfully performed the procedure in the DonauIsar-Klinikum, Deggendorf, Germany.
The TEKTONA®2 system is a vertebral fragment reduction instrument designed to assist in the reduction of vertebral body fractures using a percutaneous surgical approach.
About SpineArt
Spineart is a privately held medical device company focused on simplifying the surgical act by designing, developing and promoting safe and efficient solutions to spine surgeons, operating room teams, and patients.Spineart is a pioneer in its field, having introduced unique patented and clinically validated technologies in the fields of Minimally Invasive Surgery, Motion Preservation, Fusion, Biologics, and Fractures Treatment. Spineart markets a complete portfolio combining traceable barcoded sterile packed implants with compact instrument sets, thus proudly promoting greater safety, cost-efficiency, and compliance at the hospital.http://www.spineart.com
Congratulations to the whole team. I can’t wait to have this device in which I have believed so much from the beginning.